225 related articles for article (PubMed ID: 32298837)
1. Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).
Whyte MP; Campeau PM; McAlister WH; Roodman GD; Kurihara N; Nenninger A; Duan S; Gottesman GS; Bijanki VN; Sedighi H; Veis DJ; Mumm S
Bone; 2020 Aug; 137():115364. PubMed ID: 32298837
[TBL] [Abstract][Full Text] [Related]
2. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
Saki F; Karamizadeh Z; Nasirabadi S; Mumm S; McAlister WH; Whyte MP
J Bone Miner Res; 2013 Jun; 28(6):1501-8. PubMed ID: 23322328
[TBL] [Abstract][Full Text] [Related]
3. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S
Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546
[TBL] [Abstract][Full Text] [Related]
4. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels.
Whyte MP; Singhellakis PN; Petersen MB; Davies M; Totty WG; Mumm S
J Bone Miner Res; 2007 Jun; 22(6):938-46. PubMed ID: 17352649
[TBL] [Abstract][Full Text] [Related]
5. Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease.
Naot D; Choi A; Musson DS; Simsek Kiper PÖ; Utine GE; Boduroglu K; Peacock M; DiMeglio LA; Cundy T
Bone; 2014 Nov; 68():6-10. PubMed ID: 25108083
[TBL] [Abstract][Full Text] [Related]
6. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation.
Janssens K; de Vernejoul MC; de Freitas F; Vanhoenacker F; Van Hul W
Bone; 2005 Mar; 36(3):542-8. PubMed ID: 15777670
[TBL] [Abstract][Full Text] [Related]
7. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
Whyte MP
Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
[TBL] [Abstract][Full Text] [Related]
8. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.
Iwamoto SJ; Rothman MS; Duan S; Baker JC; Mumm S; Whyte MP
Bone; 2020 Apr; 133():115224. PubMed ID: 31923705
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin deficiency and juvenile Paget's disease.
Whyte MP; Obrecht SE; Finnegan PM; Jones JL; Podgornik MN; McAlister WH; Mumm S
N Engl J Med; 2002 Jul; 347(3):175-84. PubMed ID: 12124406
[TBL] [Abstract][Full Text] [Related]
10. Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.
Simsek S; Basoski NM; Bravenboer N; Zhang X; Mumm S; Whyte MP; Netelenbos JC
J Clin Endocrinol Metab; 2007 May; 92(5):1897-901. PubMed ID: 17284635
[TBL] [Abstract][Full Text] [Related]
11. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.
Craven M; Vajravelu ME; Shekdar KV; Levine MA; Mumm S; Whyte MP; Mancilla EE
Bone; 2023 May; 170():116698. PubMed ID: 36740137
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease].
Hosogane N; Miyamoto T
Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037
[TBL] [Abstract][Full Text] [Related]
13. Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype.
Naot D; Wilson LC; Allgrove J; Adviento E; Piec I; Musson DS; Cundy T; Calder AD
Bone; 2020 Jan; 130():115098. PubMed ID: 31655221
[TBL] [Abstract][Full Text] [Related]
14. Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation.
Prata AR; Saraiva J; Salgado M; Estanqueiro P
Joint Bone Spine; 2021 Dec; 88(6):105243. PubMed ID: 34166796
[TBL] [Abstract][Full Text] [Related]
15. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
Salmon P
J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
[TBL] [Abstract][Full Text] [Related]
16. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.
Gottesman GS; Madson KL; McAlister WH; Nenninger A; Wenkert D; Mumm S; Whyte MP
Am J Med Genet A; 2016 Apr; 170A(4):978-85. PubMed ID: 26762549
[TBL] [Abstract][Full Text] [Related]
17. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP
J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687
[TBL] [Abstract][Full Text] [Related]
18. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL.
Middleton-Hardie C; Zhu Q; Cundy H; Lin JM; Callon K; Tong PC; Xu J; Grey A; Cornish J; Naot D
J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292
[TBL] [Abstract][Full Text] [Related]
19. Juvenile Paget disease.
Polyzos SA; Cundy T; Mantzoros CS
Metabolism; 2018 Mar; 80():15-26. PubMed ID: 29080812
[TBL] [Abstract][Full Text] [Related]
20. Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.
Grasemann C; Unger N; Hövel M; Arweiler-Harbeck D; Herrmann R; Schündeln MM; Müller O; Schweiger B; Lausch E; Meissner T; Kiewert C; Hauffa BP; Shaw NJ
J Clin Endocrinol Metab; 2017 Jan; 102(1):210-219. PubMed ID: 27809640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
